EVROF — Evrofarma SA Cashflow Statement
0.000.00%
Last trade - 00:00- €25.98m
- €39.61m
- €45.72m
- 65
- 79
- 60
- 82
Annual cashflow statement for Evrofarma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.2 | -0.26 | 1.52 | 2.71 | 2.89 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.296 | 0.444 | 0.663 | 1.2 | 0.783 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.43 | -2.43 | -1.09 | -2.47 | -0.146 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.46 | -0.805 | 2.64 | 3.14 | 5.35 |
| Capital Expenditures | -0.904 | -3.35 | -1.96 | -2.46 | -1.33 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.098 | 0.08 | 0.624 | 0.437 | 2.07 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.806 | -3.27 | -1.33 | -2.02 | 0.738 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.35 | 1.21 | -0.118 | -1.9 | -3.42 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3 | -2.86 | 1.19 | -0.78 | 2.67 |